Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
72°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Insulet Corp
(NQ:
PODD
)
185.04
-0.62 (-0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Insulet Corp
< Previous
1
2
3
4
Next >
Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone
October 23, 2023
From
Insulet Corporation
Via
Business Wire
Are the S&P 500's Biggest Q3 Losers Next Year's Winners?
October 04, 2023
More than 70% of S&P 500 stocks finished in the red last quarter, but the broad-based selloff may be an opportunity - including for these three biggest losers.
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Stocks
Exposures
Artificial Intelligence
Interest Rates
US Equities
Insulet Announces CFO Transition
October 03, 2023
From
Insulet Corporation
Via
Business Wire
Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod® 5
October 02, 2023
From
Insulet Corporation
Via
Business Wire
Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
September 28, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany
August 28, 2023
From
Insulet Corporation
Via
Business Wire
Insulet to Present at Upcoming Investor Conferences
August 24, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)
August 08, 2023
From
Insulet Corporation
Via
Business Wire
Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
July 05, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions
June 22, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom
June 20, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Announces New Organizational Structure to Drive Further Growth
May 04, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)
May 04, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
May 02, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
April 25, 2023
From
Insulet Corporation
Via
Business Wire
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
March 30, 2023
From
Insulet Corporation
Via
Business Wire
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
February 24, 2023
From
Insulet Corporation
Via
Business Wire
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
February 21, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
February 14, 2023
From
Insulet Corporation
Via
Business Wire
Insulet to Present at Upcoming Investor Conferences
February 14, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
February 13, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Has Potential To Gain More Than Analysts Are Forecasting
January 18, 2023
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range.
Via
MarketBeat
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
January 12, 2023
From
Insulet Corporation
Via
Business Wire
Insulet to Present at Upcoming Investor Conferences
November 22, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
November 14, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022
November 04, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency1)
November 03, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November
November 01, 2022
From
Insulet Corporation
Via
Business Wire
Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
September 22, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System
September 20, 2022
From
Insulet Corporation
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.